ImmunoPrecise Antibodies Ltd. (IPA) is a biotechnology company specializing in the development and production of monoclonal antibodies for research, diagnostics, and therapeutic purposes. Headquartered in Canada, the company operates globally, offering services related to antibody generation and characterization, including the development of anti-cancer and immunotherapeutic antibodies. ImmunoPrecise Antibodies focuses on providing high-quality and specialized products for various industries and research institutions. Shares of ImmunoPrecise Antibodies Ltd. (IPA) are listed on the Canadian stock exchange and can be an appealing choice for investors seeking investment opportunities in the biotechnology and healthcare research sector.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
